Suppression of Endothelial Progenitor Cells in Human Coronary Artery Disease by the Endogenous Nitric Oxide Synthase Inhibitor Asymmetric Dimethylarginine
Open Access
- 10 October 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (9), 1693-1701
- https://doi.org/10.1016/j.jacc.2005.04.066
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1Biochemical and Biophysical Research Communications, 2004
- Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide SynthaseCirculation, 2004
- Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemiaClinical Science, 2004
- Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemiaThe American Journal of Cardiology, 2004
- Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral SupportCirculation, 2004
- Therapeutic Angiogenesis and Vasculogenesis for Ischemic DiseaseCirculation, 2004
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004
- Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation, 2004
- Erythropoietin regulates endothelial progenitor cellsBlood, 2004